Austrian Pharma Co.'s €142M Award Nixed In Germany
A German court has set aside a €142 million ($161.8 million) damages award issued to Austrian pharmaceutical company AOP Orphan in the midst of a contentious dispute with Taiwanese drug developer...To view the full article, register now.
Already a subscriber? Click here to view full article